Endpoints News is a specialist news publisher covering the biopharma and biotechnology industries. The site delivers day‑to‑day reporting, analysis, and interviews across drug discovery, R&D, deals, regulatory (FDA+), manufacturing, and the business of life sciences. Its audience includes scientists, industry executives, investors, and policy makers who rely on timely, sector‑specific journalism.

Endpoints produces topical channels and hubs, editorial features, newsletters, webinars, and events to provide market intelligence and context for the biotech and pharma communities. The site hosts dedicated topic pages (e.g., AI drug discovery, cell/gene therapy, GLP‑1 drugs) and regular feeds on financing, people moves, and regulatory developments.

Endpoints runs a dedicated careers/jobs portal and advertises roles via recruiting partners. The organisation also partners with industry for sponsored content, webinars, and recruitment services while maintaining editorial standards and a newsroom focus on accurate reporting.